Michele Porreca
Human Resources Officer bij PRELUDE THERAPEUTICS INCORPORATED
Oorsprong van het eerstegraads netwerk van Michele Porreca
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 22 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Michele Porreca via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| INCYTE CORPORATION | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Administrative Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member Compliance Officer General Counsel Director of Finance/CFO | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Sales & Marketing Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| LOXO ONCOLOGY INC | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| MADRIGAL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director of Finance/CFO | |
| University of Wisconsin | College/University | Doctorate Degree Undergraduate Degree | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree | |
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a precision medicines company called Esker that aims to provide personalized treatments for people with autoimmune diseases. The company is based in San Francisco, CA. Esker uses a precision analytics platform, powered by foresite labs, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology to create medicines that change the lives of people with autoimmune disease. The company was founded by June H Lee. Martin Babler has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree | |
| Acharya N. G. Ranga Agricultural University | College/University | Undergraduate Degree | |
| University of Florida | College/University | Doctorate Degree | |
| Orsenix LLC | Chief Executive Officer | ||
| Michigan State University | College/University | Undergraduate Degree | |
| University of Pennsylvania | College/University | Doctorate Degree | |
| KYMERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Istari Oncology, Inc.
 Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC. | Biotechnology | Director/Board Member | |
| ADC THERAPEUTICS SA | Pharmaceuticals: Major | Director/Board Member | |
| MERUS N.V. | Biotechnology | Director/Board Member | |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| McGill University | College/University | Doctorate Degree | |
Shire Pharmaceuticals LLC
 Shire Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals LLC is an American company that manufactures pharmaceutical products. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Robert H. Smith School of Business | College/University | Masters Business Admin | |
Otsuka Pharmaceutical Development & Commercialization, Inc.
 Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Notre Dame | College/University | Undergraduate Degree | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Sardona Therapeutics, Inc. | Director/Board Member | ||
| 89BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ZS PHARMA INC | Pharmaceuticals: Major | Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
| OMEGA ALPHA SPAC | Financial Conglomerates | Director/Board Member | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| APTEVO THERAPEUTICS INC. | Biotechnology | Investor Relations Contact | |
| ALTIMMUNE, INC. | Biotechnology | Investor Relations Contact | |
| BEIGENE, LTD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Baker Bros. Advisors LP
 Baker Bros. Advisors LP Investment ManagersFinance Baker Bros. Advisors LP (BBA) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Julian Baker and Felix Baker in 2000 and do-business-as Baker Brothers Investments. BBA serves as a discretionary investment advisor to pooled investment vehicles operating as private investment funds and to a managed account. | Investment Managers | Founder | |
| Washington University School of Medicine | College/University | Doctorate Degree | |
| Andhra University | College/University | Undergraduate Degree | |
| TREVENA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistieken
Internationaal
| Verenigde Staten | 43 |
| India | 3 |
| Kaaimaneilanden | 3 |
| Israël | 2 |
| Zwitserland | 2 |
Sectoraal
| Health Technology | 32 |
| Consumer Services | 13 |
| Finance | 4 |
| Commercial Services | 2 |
Operationeel
| Director/Board Member | 73 |
| Independent Dir/Board Member | 44 |
| Corporate Officer/Principal | 39 |
| Undergraduate Degree | 18 |
| Chief Tech/Sci/R&D Officer | 13 |
Sterkste connecties
| Insiders | |
|---|---|
| David Bonita | 27 |
| Paul Friedman | 21 |
| Julian Baker | 20 |
| Mardi Dier | 18 |
| Martin Babler | 13 |
| Deborah Morosini | 10 |
| Bryant Lim | 9 |
| Victor Sandor | 9 |
| Laurent Chardonnet | 8 |
| Brian Piper | 8 |
| Jane Huang | 8 |
| Andrew Combs | 7 |
| Christopher Pierce | 6 |
| Aimee Crombie | 5 |
| Krishna Vaddi | 5 |
- Beurs
- Insiders
- Michele Porreca
- Bedrijfsconnecties
